From: Soluble fibrinogen-like protein 2 levels in patients with hepatitis B virus-related liver diseases
Characteristics | AHB (n = 29) | CHB (n = 73) | LC (n = 70) | HCC (n = 99) | LC + HCC (n = 25) | HC (n = 158) | P value |
---|---|---|---|---|---|---|---|
Age (median, range) | 32 (17–70) | 39.5 (20–76) | 48 (17–74) | 50 (15–79) | 56 (37–81) | 31 (19–38) | <  0.001 |
Gender (male/female) | 23/6 | 55/18 | 54/16 | 84/15 | 25/0 | 112/46 | <  0.001 |
Liver cirrhosis stage: | |||||||
 Child-Pugh A (n,%) | NA | NA | 22 (49%)a | NA | 15 (60%) | NA | NA |
 Child-Pugh B (n,%) | NA | NA | 12 (28%)a | NA | 8 (32%) | NA | NA |
 Child-Pugh C (n,%) | NA | NA | 10 (23%)a | NA | 2 (8%) | NA | NA |
RBC (×103/ml) | NA | 6.7 (4.5–13.9) | 6 (2.7–20.5) | 5.8 (4–11) | 5.7 (2.7–11) | NA | <  0.01 |
WBC (× 106/ml) | NA | 4.9 (4.1–5.3) | 4.3 (2.3–6.7) | 4.9 (4.2–6) | 4.5 (3–6) | NA | <  0.001 |
PLT (×103/ml) | NA | 168.5 (61–355) | 87.5 (49–299) | 196 (101–361) | 122 (35–237) | NA | <  0.001 |
AST (IU/L) | 1109 (115.5–4593) | 143 (77–657) | 71 (16.8–1059) | 67 (14–371) | 63 (25–655) | NA | <  0.001 |
ALT (IU/L) | 861.5 (182–4425) | 144 (89–1643) | 57 (8–1426) | 50.5 (3–471) | 54 (22–551) | NA | <  0.001 |
Total-Bilirubin (mg/dl) | 132 (21.8–558) | 22.5 (12–412) | 30.3 (6.5–722) | 19 (5.1–282) | 23 (9–185) | NA | <  0.001 |
Direct-Bilirubin (mg/dl) | 117.3 (14.3–512) | 12.4 (6.2–292.3) | 14 (1.3–450) | 8.8 (2–189.4) | 8 (2–59) | NA | <  0.001 |
Albumin (g/L) | NA | 42 (33–50) | 32.5 (25–39) | 39 (30–47) | 38 (27–44) | NA | <  0.01 |
Prothrombin (%) | 85 (50–120) | 76 (26–122) | 46 (15–100) | 78 (37–100) | 77 (19.6–117) | NA | <  0.01 |
HBV-DNA (log10 copies/ml) | 3.96 (3.5–5.7) | 4.2 (2.8–4.66) | 4.1 (2.8–6.4) | 3.98 (2.5–8.9) | 6 (2.3–10.4) | NA | <  0.001 |
Alpha fetoprotein (IU/L) | NA | 12.5 (2–151) | 6.7 (1.2–1050) | 96.7 (1.5–1050) | 113 (2–300) | NA | <  0.001 |